Replies to post #3777 on Phio Pharmaceuticals Corp (PHIO)

[Titan V]

Yup.

Btw I wouldn't be surprised if RXI get's snatched up by a domestic or foreign big pharma/biotech in the next 6-8 months. They've publicly announced their intent to M&A. They've hired an investment bank (Griffin) to look for business development or M&A "transactions". In normal industry partnerships between two companies, you don't hear an investment bank being involved in the advisory. But in an acquisition, you read that the two parties were advised by so and so banks. They are also low on cash to move ahead on their own and haven't raised recently. All signs of a potential sale IMO. I think they're waiting to release data to strike a deal at a higher SP.

Even with a lowball sale at $100M, that's $15 a share - very attractive if you've recently bought in or averaged down like me. I personally hope it's at least $200M+ but I don't see Rxi going to market on its own. Maybe a partnership and big upfront from the partner will change things but that has been elusive so far.

RXi Pharmaceuticals Corporation (Nasdaq: RXII) announced that it is in the process of exploring strategic options including a range of potential M&A and business development opportunities designed to enhance shareholder value. As part of this effort, RXi has engaged Griffin Securities, Inc. ("Griffin") for one of these transactions.
...
There can be no assurance that the exploration of strategic alternatives will result in a transaction. The Company does not intend to provide updates unless or until it determines that disclosure is appropriate or necessary.

http://www.streetinsider.com/Corporate+News/RXI+Pharma+(RXII)+Will+Explore+Strategic+Options,+Including+Possible+M%26A/11608089.html